Cellebrite DI Ltd. (CLBT) |
|
4.72 0.1 (2.16%)
|
05-18 01:58 |
|
Open: |
4.7 |
Pre. Close: |
4.62 |
|
High:
|
4.755 |
Low:
|
4.56 |
|
Volume:
|
98,429 |
Market Cap:
|
890(M) |
|
|
|
|
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.76 - 4.79 |
4.79 - 4.82 |
|
Low:
|
4.5 - 4.53 |
4.53 - 4.56 |
|
Close:
|
4.67 - 4.73 |
4.73 - 4.77 |
|
Technical analysis |
as of: 2022-05-17 4:45:59 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 6.26 One year: 7.17 |
| Support: |
Support1: 4.09 Support2: 3.41 |
| Resistance: |
Resistance1: 5.36 Resistance2: 6.13 |
| Pivot: |
5.03  |
| Moving Average: |
MA(5): 4.77 MA(20): 5.09
MA(100): 6.34 MA(250): 8.45 |
| MACD: |
MACD(12,26): -0.4  Signal(9): -0.4 |
| Stochastic oscillator: |
%K(14,3): 48.2 %D(3): 43.1 |
| RSI: |
RSI(14): 39.7 |
| 52-week: |
High: 13.23 Low: 4.09 |
| Average Vol(K): |
3-Month: 283 (K) 10-Days: 167 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CLBT ] has closed above bottom band by 20.6%. Bollinger Bands are 39.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 17 May 2022
Cellebrite DI (NASDAQ:CLBT) Rating Lowered to Sell at Zacks Investment Research - Defense World
Thu, 12 May 2022
Cellebrite Announces First Quarter 2022 Results - Crypto Reporter
Thu, 12 May 2022
Cellebrite DI Ltd. (CLBT) CEO Yossi Carmil on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha
Thu, 05 May 2022
Cellebrite to Showcase Advanced Access as a Service at the Techno Security & Digital Forensics Conference - GlobeNewswire
Fri, 29 Apr 2022
Should You Buy Cellebrite DI Ltd (CLBT) Stock After it Is Up 6.64% in a Week? - InvestorsObserver
Mon, 25 Apr 2022
Comparing Qualtrics International (NYSE:XM) and Cellebrite DI (NASDAQ:CLBT) - Defense World
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Technology |
| Industry: Software—Infrastructure |
| Shares Out. |
187 (M) |
| Shares Float |
28 (M) |
|
% Held by Insiders
|
7.5 (%) |
|
% Held by Institutions
|
11.8 (%) |
|
Shares Short
|
1,930 (K) |
|
Shares Short P.Month
|
1,720 (K) |
Stock Financials |
|
EPS
|
0.05 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-0.9 |
|
Profit Margin (%)
|
9.5 |
|
Operating Margin (%)
|
6.1 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
23.7 |
|
Gross Profit (p.s.)
|
0.83 |
|
Sales Per Share
|
1.25 |
|
EBITDA (p.s.)
|
0.11 |
|
Qtrly Earnings Growth
|
66.6 |
|
Operating Cash Flow
|
38 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
94.39 |
|
PEG Ratio
|
2.9 |
|
Price to Book value
|
-5.25 |
|
Price to Sales
|
3.75 |
|
Price to Cash Flow
|
23.03 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
